Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Miglustat hydrochloride (N-Butyldeoxynojirimycin hydrochloride) is an inhibitor of glucosylceramide synthase and can be used for studies about Type I Gaucher disease.
別名 | NB-DNJ hydrochloride, N-Butyldeoxynojirimycin hydrochloride, OGT918 hydrochloride |
分子量 | 255.74 |
分子式 | C10H22ClNO4 |
CAS No. | 210110-90-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 34 mg/mL (132.95 mM)
DMSO: 60 mg/mL (234.61 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Miglustat hydrochloride 210110-90-0 Metabolism Transferase N-Butyldeoxynojirimycin Hydrochloride N-Butyldeoxynojirimycin NB-DNJ hydrochloride OGT-918 type I gaucher disease Miglustat oral Glucosylceramide Synthase (GCS) OGT918 Miglustat Hydrochloride OGT918 Hydrochloride ceramide glucosyltransferase NB-DNJ Inhibitor inhibit OGT 918 OGT 918 Hydrochloride N-Butyldeoxynojirimycin hydrochloride OGT-918 Hydrochloride OGT918 hydrochloride NB-DNJ Hydrochloride inhibitor